| Nasdaq: ARQL
ArQule, Inc. is a clinical-stage biotechnology company that is engaged in the research and development of cancer therapeutics. Its products and research programs focuses on key biological processes that are central to human cancers. The company's programs also include research and development, drug discovery and advanced clinical testing. Its proprietary pipeline is directed towards molecular targets and biological processes with demonstrated roles in the development of human cancers. The company was founded in 1993 and is headquartered in Woburn, MA.